Gene therapy involves the delivery of complex treatments to patients.
GlobalData’s Clinical Trials Database is a comprehensive source of information on clinical trials worldwide, providing accurate and detailed intelligence to address your clinical development needs. The database covers interventional, observational and expanded access studies involving therapeutic and prophylactic interventions for a wide range of therapy areas and indications, including rare diseases.
Why choose GlobalData’s Clinical Trials Database?
– Save time and effort by gaining access to accumulated information from various sources and registries in a standardized format, reducing the need for research.
– Monitor and evaluate a product’s clinical development and use our Clinical Trial Analyzers to customize data evaluation.
– Access GlobalData’s other databases covering Pharmaceutical Products, Investigators, Companies and News, which are seamlessly integrated with the Clinical Trials Database.
– Visualize and analyze competitors’ clinical stage portfolios using the Competitive Landscape tool.
– Gain access to a 24/7 ‘Ask an Analyst Support Service’, plus research support and training.
Request a free demo
Europe: +44 20 7406 6648
North America: +1 646 395 5460
Asia-Pacific: +91 40 6616 6700
This whitepaper provides a review of global clinical trials with a start date between 1 January and 31 December 2018.
Scotty Chung-Siu, Brooke Wilson & Revati Tatake, GlobalData, examine developments in the Russian clinical trial space
In an exclusive white paper, Brooke Wilson, Revati Tatake & Bonnie Bain, GlobalData, assess the clinical trial landscape in Brazil
This whitepaper provides a review of Phase I to Phase IV clinical trials with a start date between January 1, 2001 and June 5, 2018, and which have a trial location in South Korea.
This whitepaper provides a review of the enrollment trends of Phase I to Phase IV clinical trials that had a start date between January 1, 2001 and December 31, 2018 and a trial location in India.
Brooke Wilson, Bonnie Bain, PhD & Revati Tatake, PhD, GlobalData, examine patient recruitment trends in Chinese clinical trials
Amina Abukar, MSc, Brooke Wilson & Revati Tatake, PhD, GlobalData, examine the microbiome in clinical trials
Revati Tatake & Brooke Wilson, GlobalData, provide an overview of developments that arose in the clinical trial space in 2017
This white paper by GlobalData provides an outlook on the clinical trial landscape for 2017
GlobalData assess the CT landscape in China
GlobalData document and analyze all clinical trials that have been terminated across a five year span
GlobalData assess 2015 trends that emerged from clinical trials conducted in the Nordics
GlobalData's latest white paper takes a retrospective look on the CT landscape in the last five years
In its latest white paper, GlobalData assesses the implications of the Brexit vote on UK clinical research
Read GlobalData's White Paper focusing on the increasing influence of CROs in the clinical trial space
GlobalData provide an overview of the CT landscape in the Asia-Pacific region
Check out GlobalData's latest White Paper about Clinical Trials in Europe
The latest Whitepaper by GlobalData looks at Obesity Clinical Trials
The latest Whitepaper by GlobalData looks at Clinical Trials for Schizophrenia